Specifically, Nano-reshaper induced more Trp-2-specific CD8+ T cells in tumors than 5% Glu, ApoE-CaCP and ApoE-pLIGHT@CaP (Fig. 6i and Supplementary Fig. 28), demonstrating the enhanced anti-GBM specific immune response. This evidence concerns the gene CD8A and glioblastoma.